美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA204779"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
70518-0608-0 70518-0608 HUMAN PRESCRIPTION DRUG Lithium Carbonate Lithium Carbonate TABLET, EXTENDED RELEASE ORAL 20170706 N/A ANDA ANDA204779 REMEDYREPACK INC. LITHIUM CARBONATE 300 mg/1 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-0608-0)
64980-205-05 64980-205 HUMAN PRESCRIPTION DRUG Lithium Carbonate Lithium Carbonate TABLET, EXTENDED RELEASE ORAL 20160323 N/A ANDA ANDA204779 Rising Pharmaceuticals, Inc. LITHIUM CARBONATE 300 mg/1 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-205-05)
64980-205-03 64980-205 HUMAN PRESCRIPTION DRUG Lithium Carbonate Lithium Carbonate TABLET, EXTENDED RELEASE ORAL 20160323 N/A ANDA ANDA204779 Rising Pharmaceuticals, Inc. LITHIUM CARBONATE 300 mg/1 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-205-03)
64980-205-01 64980-205 HUMAN PRESCRIPTION DRUG Lithium Carbonate Lithium Carbonate TABLET, EXTENDED RELEASE ORAL 20160323 N/A ANDA ANDA204779 Rising Pharmaceuticals, Inc. LITHIUM CARBONATE 300 mg/1 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-205-01)
64980-205-09 64980-205 HUMAN PRESCRIPTION DRUG Lithium Carbonate Lithium Carbonate TABLET, EXTENDED RELEASE ORAL 20160323 N/A ANDA ANDA204779 Rising Pharmaceuticals, Inc. LITHIUM CARBONATE 300 mg/1 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-205-09)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase